COSCIENS Biopharma Inc 20-F, filed Apr 9, 2025
COSCIENS Biopharma Inc. (CSCIF)
20-F
2025-04-09
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 20-F
COSCIENS Biopharma Inc filed this 20-F on April 9, 2025, covering the fiscal year ended December 31, 2024.
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.59M
- up 34.2% from $7.14M a year earlier
- Net loss
- $15.31M
- compared with a net loss of $3.49M a year earlier
- Diluted EPS
- -$5.93
- compared with -$1.89 a year earlier